Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
Virax Biolabs Group Ltd. Class A (VRAX) Stock Price & Analysis
26 Followers
VRAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.70 - $8.54
Previous Close$0.71
Volume9.36K
Average Volume (3M)96.26K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$9.35M
Total Debt (Recent Filing)$146.25K
Price to Earnings (P/E)-0.2
Beta0.15
Next Earnings
Feb 02, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.22
Shares Outstanding1,555,000
10 Day Avg. Volume17,018
30 Day Avg. Volume96,263
Standard Deviation0.21
R-Squared0.06
Alpha-0.17
Financial Highlights & Ratios
Price to Book (P/B)0.13
Price to Sales (P/S)128.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Virax Biolabs Group Ltd. Class A News
PremiumCompany Announcements
Virax Biolabs Debuts ImmuneSelect Portfolio
PremiumCompany Announcements
Virax Biolabs Showcases Innovations at ESCMID 2024
Ownership Overview
0.00%
Insiders
0.23% Mutual Funds
5.17% Other Institutional Investors
94.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
VRAX FAQ
What was Virax Biolabs Group Ltd. Class A’s price range in the past 12 months?
Virax Biolabs Group Ltd. Class A lowest stock price was $0.70 and its highest was $8.54 in the past 12 months.
What is Virax Biolabs Group Ltd. Class A’s market cap?
Currently, no data Available
When is Virax Biolabs Group Ltd. Class A’s upcoming earnings report date?
Virax Biolabs Group Ltd. Class A’s upcoming earnings report date is Feb 02, 2023 which is 452 days ago.
How were Virax Biolabs Group Ltd. Class A’s earnings last quarter?
Currently, no data Available
Is Virax Biolabs Group Ltd. Class A overvalued?
According to Wall Street analysts Virax Biolabs Group Ltd. Class A’s price is currently Overvalued.
Does Virax Biolabs Group Ltd. Class A pay dividends?
Virax Biolabs Group Ltd. Class A does not currently pay dividends.
What is Virax Biolabs Group Ltd. Class A’s EPS estimate?
Virax Biolabs Group Ltd. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virax Biolabs Group Ltd. Class A have?
Virax Biolabs Group Ltd. Class A has 2,361,903 shares outstanding.
What happened to Virax Biolabs Group Ltd. Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Virax Biolabs Group Ltd. Class A?
Currently, no hedge funds are holding shares in VRAX
---
Virax Biolabs Group Ltd. Class A Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.78%
12-Months-Change
Fundamentals
Return on Equity
-129.10%
Trailing 12-Months
Asset Growth
32.58%
Trailing 12-Months
Company Description
Virax Biolabs Group Ltd. Class A
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology.
---
Technical Analysis
---